Do you alter definitive treatment recommendations for oropharynx p16+ cancers based on the new staging?
The new AJCC staging factors in HPV status and can drastically alter a patients overall stage group, hence dramatically change definitive treatment recommendations from CRT to RT alone compared to the old staging.
2 Answers
Mednet MemberInvited Expert
Radiation Oncology · Levine Cancer Institute
Answered on
As you know, the new 8th Edition of the AJCC staging manual redefined prognostic staging for p16/HPV-positive tumors. It is important to note that p16/HPV is therefore not a PROGNOSTIC marker but rather a DIAGNOSTIC biomarker of a different disease entity entirely. The 8th Edition system is based of...
Join for free or sign in to see the full answer
Mednet MemberInvited Expert
Radiation Oncology · Virginia Commonwealth University Health System
Answered on
We have not altered definitive treatment recommendations for p16+ oropharyngeal cancer since the introduction of the new AJCC staging.
Join for free or sign in to see the full answer